Literature DB >> 23999973

Comment on: "Management of alcohol dependence in patients with liver disease".

Benjamin Rolland1, Sylvie Deheul, Alexandre Louvet, Olivier Cottencin, Régis Bordet.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23999973     DOI： 10.1007/s40263-013-0109-3

Source DB:  PubMed          Journal:  CNS Drugs        ISSN： 1172-7047            Impact factor:   5.749


× No keyword cloud information.
  10 in total

1.  Alcohol-dependence: the current French craze for baclofen.

Authors:  Benjamin Rolland; Régis Bordet; Olivier Cottencin
Journal:  Addiction       Date:  2012-02-11       Impact factor: 6.526

2.  Abstinence and 'low-risk' consumption 1 year after the initiation of high-dose baclofen: a retrospective study among 'high-risk' drinkers.

Authors:  Laurent Rigal; Constance Alexandre-Dubroeucq; Renaud de Beaurepaire; Claire Le Jeunne; Philippe Jaury
Journal:  Alcohol Alcohol       Date:  2012-03-19       Impact factor: 2.826

3.  Suppression of symptoms of alcohol dependence and craving using high-dose baclofen.

Authors:  William Bucknam
Journal:  Alcohol Alcohol       Date:  2006-12-15       Impact factor: 2.826

4.  Dose-response effect of baclofen in reducing daily alcohol intake in alcohol dependence: secondary analysis of a randomized, double-blind, placebo-controlled trial.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Giorgio Bedogni; Fabio Caputo; Giovanni Gasbarrini; Raffaele Landolfi
Journal:  Alcohol Alcohol       Date:  2011-03-17       Impact factor: 2.826

5.  Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician.

Authors:  Olivier Ameisen
Journal:  Alcohol Alcohol       Date:  2004-12-13       Impact factor: 2.826

6.  High-dose baclofen for treatment-resistant alcohol dependence.

Authors:  Adam Pastor; David Martyn Lloyd Jones; Jon Currie
Journal:  J Clin Psychopharmacol       Date:  2012-04       Impact factor: 3.153

Review 7.  Management of alcohol dependence in patients with liver disease.

Authors:  Giovanni Addolorato; Antonio Mirijello; Lorenzo Leggio; Anna Ferrulli; Raffaele Landolfi
Journal:  CNS Drugs       Date:  2013-04       Impact factor: 5.749

Review 8.  GABAergic transmission in hepatic encephalopathy.

Authors:  Olga A Sergeeva
Journal:  Arch Biochem Biophys       Date:  2013-04-23       Impact factor: 4.013

9.  Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.

Authors:  Giovanni Addolorato; Lorenzo Leggio; Anna Ferrulli; Silvia Cardone; Luisa Vonghia; Antonio Mirijello; Ludovico Abenavoli; Cristina D'Angelo; Fabio Caputo; Antonella Zambon; Paul S Haber; Giovanni Gasbarrini
Journal:  Lancet       Date:  2007-12-08       Impact factor: 79.321

10.  Suppression of alcohol dependence using baclofen: a 2-year observational study of 100 patients.

Authors:  Renaud de Beaurepaire
Journal:  Front Psychiatry       Date:  2012-12-03       Impact factor: 4.157
  10 in total
  1 in total

1.  Authors' reply to Rolland et al.: "Management of alcohol dependence in patients with liver disease".

Authors:  Giovanni Addolorato; Antonio Mirijello
Journal:  CNS Drugs       Date:  2013-10       Impact factor: 5.749
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.